Stay updated with breaking news from Billy Cho. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Start Time: 08:00 End Time: 08:48 Zai Lab Limited (NASDAQ:NASDAQ:ZLAB) Q1 2022 Earnings Conference Call May 11, 2022, 08:00 AM ET Company Participants Samantha Du - Founder, Chairperson and...
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, and Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an...
Zai Lab Announces Financial Results for Second-half and Full-year 2020 March 01, 2021 07:00 ET | Source: Zai Lab Limited Zai Lab Limited -- Company to Host Conference Call and Webcast Today at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported financial results for the second half and full year of 2020, along with corporate updates. “2020 was another year of great accomplishment for Zai Lab,” said Dr. Samantha Du, Founder,...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China Zai Lab Limited; argenxJanuary 6, 2021 GMT Collaboration to expand and accelerate global development of efgartigimod; expected to allow argenx to more rapidly advance new potential indications into clinical development each year Zai Lab granted exclusive rights to develop and commercialize efgartigimod in Greater China argenx to receive $75 million in upfront Zai Lab equity and $100 million in near-term milesto...
Zai Lab Announces Upcoming Presentation at 39th Annual J.P. Morgan Healthcare Conference